SCHEMBL13152103

SCHEMBL13152103

COc1ccc(-n2cc(N)c3ccc(NC(=O)NC(C)(C)C)cc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.44
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 6/20 0.41
RAB9A P51151 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
TP53 P04637 3/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 2/20 0.40
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10095328 0.85 IMPDH2 (0.47) MEN1KMT2ASMN1; SMN2HPGDALDH1A1
SCHEMBL10254742 0.79 SMN1; SMN2 (0.46) MAPK8KDM4EKMT2ANPC1RAB9A
SCHEMBL15946355 0.74 RAB9A (0.72) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL10254740 0.74 ALDH1A1 (0.52) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL13152691 0.72 KDM1A (0.44) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL14176085 0.72 SSTR5 (0.49) KDM4EALDH1A1
SCHEMBL13152592 0.71 ALDH1A1 (0.42) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL13152153 0.71 PMM2 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL10095308 0.70 IMPDH2 (0.49) KDM4EMEN1KMT2ASMN1; SMN2HPGD
SCHEMBL13153385 0.68 HTT (0.49) KDM4EMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 WO disclosed